A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus
Phase 3
- Conditions
- The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mgPlus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks inSubjects With Type 2 Diabetes Mellitus.
- Interventions
- Drug: Metformin/Acarbose
- First Posted Date
- 2010-11-22
- Last Posted Date
- 2010-11-22
- Lead Sponsor
- Lotus Pharmaceutical
- Target Recruit Count
- 220
- Registration Number
- NCT01245166
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
Phase 4
- Conditions
- Chronic Idiopathic UrticariaUrticaria
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2006-06-30
- Lead Sponsor
- Lotus Pharmaceutical
- Target Recruit Count
- 60
- Registration Number
- NCT00346606
- Locations
- 🇨🇳
Department of Dermatology National Taiwan University Hospital, Taipei, Taiwan
Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
Phase 3
Completed
- Conditions
- Migraine With AuraMigraine Without Aura
- First Posted Date
- 2006-06-06
- Last Posted Date
- 2007-09-10
- Lead Sponsor
- Lotus Pharmaceutical
- Target Recruit Count
- 74
- Registration Number
- NCT00334178
- Locations
- 🇨🇳
Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
🇨🇳Taipei Medical University Hospital, Taipei, Taiwan
🇨🇳Changhua Christian Hospital, Changhua, Taiwan
© Copyright 2025. All Rights Reserved by MedPath